Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 8/20 | 0.49 |
| ▸ | NAALAD2 | Q9Y3Q0 | 2/20 | 0.49 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.49 |
| ▸ | NOD1 | Q9Y239 | 3/20 | 0.46 |
| ▸ | GNPAT | O15228 | 1/20 | 0.43 |
| ▸ | BMP1 | P13497 | 2/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22316165 | 0.87 | FOLH1 (0.62) | FOLH1NAALAD2RIMKLAGNPATBMP1 | |
| SCHEMBL22316576 | 0.86 | FOLH1 (0.60) | FOLH1NAALAD2RIMKLAGNPATBMP1 | |
| SCHEMBL19619057 | 0.86 | FOLH1 (0.60) | FOLH1NAALAD2RIMKLANOD1GNPAT | |
| SCHEMBL18271261 | 0.86 | FOLH1 (0.60) | FOLH1NAALAD2RIMKLANOD1GNPAT | |
| SCHEMBL14169172 | 0.86 | FOLH1 (0.60) | FOLH1NAALAD2RIMKLANOD1GNPAT | |
| SCHEMBL22315882 | 0.86 | FOLH1 (0.60) | FOLH1NAALAD2RIMKLAGNPATBMP1 | |
| SCHEMBL22315435 | 0.86 | FOLH1 (0.60) | FOLH1NAALAD2RIMKLAGNPATBMP1 | |
| SCHEMBL23875397 | 0.84 | FOLH1 (0.47) | FOLH1NAALAD2RIMKLANOD1GNPAT | |
| SCHEMBL22695976 | 0.84 | FOLH1 (0.50) | FOLH1NAALAD2RIMKLANOD1GNPAT | |
| SCHEMBL24234681 | 0.82 | FOLH1 (0.51) | FOLH1NAALAD2RIMKLANOD1GNPAT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022022354-A1 | POLYETHYLENE GLYCOL CONJUGATE DRUG SYNERGIST, PREPARATION METHOD THEREFOR, AND USE THEREOF | 重庆阿普格雷生物科技有限公司 | 2022-02-03 | — | — | WO | disclosed |